Clinical Trial Update: Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes [Phase 3]

View source ↗

Summary

Phase 3 long-term study to evaluate the safety and efficacy of Saroglitazar Magnesium-V in participants with Primary Biliary Cholangitis; trial status currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Saroglitazar Magnesium-V (saroglitazar)

Snippet

Sponsor: Zydus Therapeutics Inc. | Conditions: Primary Biliary Cholangitis | Phase 3 | Status: NOT_YET_RECRUITING